Induction of CD95 upregulation does not render chronic lymphocytic leukemia B-cells susceptible to CD95-mediated apoptosis

Immunology Letters

Volumn 97, Issue 1, 2005, Pages 131-139

  Romano, Ciro ^a   Fanis, Umberto De ^a   Sellitto, Ausilia ^a   Chiurazzi, Federico ^b   Guastafierro, Salvatore ^c   Giunta, Riccardo ^a   Tirelli, Angelo ^c   Rotoli, Bruno ^b   Lucivero, Giacomo ^a  

^a Allergy and Clinical Immunology   (Italy)

^b University Schools   (United States)

^c Division of Hematology   (Italy)

Author keywords

Apoptosis; B CLL; CD95; Cytokines; IFN ; T lymphocytes

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MONOCLONAL ANTIBODY;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN INDUCTION; STAINING; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; CYTOKINES; HUMANS; INTERFERON TYPE II; LEUKEMIA, B-CELL, CHRONIC; UP-REGULATION;

EID: 11144348655     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.09.022     Document Type: Article

References (38)

1. M.J. Keating Chronic lymphocytic leukemia Semin Oncol 26 1999 107 114
2. T.J. Kipps Chronic lymphocytic leukemia Curr Opin Hematol 7 2000 223 234
3. F. Caligaris-Cappio Biology of chronic lymphocytic leukemia Rev Clin Exp Hematol 4 2000 5 21
4. P.H. Krammer CD95's deadly mission in the immune system Nature 407 2000 789 795
5. R.C. Budd Activation-induced cell death Curr Opin Immunol 13 2001 356 362
6. U. De Fanis, L. Dalla Mora, C. Romano, A. Sellitto, A. Tirelli, and G. Lucivero Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia Haematologica 87 2002 325 327
7. U. De Fanis, C. Romano, L. Dalla Mora, A. Sellitto, S. Guastafierro, A. Tirelli, E. Bresciano, R. Giunta, and G. Lucivero Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells Oncol Rep 10 2003 653 658
8. S. Molica, A. Mannella, A. Dattilo, D. Levato, F. Iuliano, A. Peta, C. Consacrino, and S. Magro Differential expression of bcl-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells: a flow cytometric analysis Haematologica 81 1996 302 309
9. S. Kamihira, Y. Yamada, Y. Hirakata, K. Tsuruda, K. Sugahara, M. Tomonaga, T. Maeda, K. Tsukasaki, S. Atogami, and N. Kobayashi Quantitative characterization and potential function of Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias Br J Haematol 99 1997 858 865
10. P. Panayiotidis, K. Ganeshaguru, L. Foroni, and A.V. Hoffbrand Expression and function of the Fas antigen in B chronic lymphocytic leukemia and hairy cell leukemia Leukemia 9 1995 1227 1232
11. C. van Kooten, and J. Banchereau CD40-CD40 ligand J Leuk Biol 67 2000 2 17
12. L.E. Van den Hove, S.W. Van Gool, P. Vandenberghe, M. Bakkus, K. Thielemans, M.A. Boogaerts, and J.L. Ceuppens CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules Leukemia 11 1997 572 580
13. W.G. Wierda, M.J. Cantwell, S.J. Woods, L.Z. Rassenti, C.E. Prussak, and T.J. Kipps CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia Blood 96 2000 2917 2924
14. C. Romano, U. De Fanis, A. Sellitto, L. Dalla Mora, F. Chiurazzi, R. Giunta, B. Rotoli, and G. Lucivero Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells Leuk Lymphoma 44 2003 1963 1971
15. M. Cantwell, T. Hua, J. Pappas, and T.J. Kipps Acquired CD40-ligand deficiency in chronic lymphocytic leukemia Nat Med 3 1997 984 989
16. C. Kneitz, M. Goller, M. Wilhelm, C. Mehringer, G. Wohlleben, A. Schimpl, and H.P. Tony Inhibition of T cell/B cell interaction by B-CLL cells Leukemia 13 1999 98 104
17. K.R. Rai, A. Sawitsky, E.P. Cronkite, A.D. Chanana, R.N. Levy, and B.S. Pasternack Clinical staging of chronic lymphocytic leukemia Blood 46 1975 219 234
18. E. Reichmann The biological role of the Fas/FasL system during tumor formation and progression Semin Cancer Biol 12 2002 309 315
19. R. Buhmann, A. Nolte, D. Westhaus, B. Emmerich, and M. Hallek CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells Blood 93 1999 1992 2002
20. D. King, J.H. Pringle, M. Hutchinson, and G.M. Cohen Processing/ activation of caspases, -3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cells Leukemia 12 1998 1553 1560
21. S. Scrivener, E.R. Kaminski, A. Demaine, and A.G. Prentice Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukemia: evidence of immune dysregulation Br J Haematol 112 2001 959 964
22. N. Chiorazzi, S.F. Fu, G. Montazeri, H.G. Kunkel, K. Rai, and T. Gee T cell helper defect in patients with chronic lymphocytic leukemia J Immunol 122 1979 1087 1090
23. + tumor cells in B chronic lymphocytic leukemia Blood 91 1998 4273 4281
24. G. Lucivero, J.T. Prchal, A.R. Lawton, S. Antonaci, and L. Bonomo Abnormal T-cell function in B-cell chronic lymphocytic leukemia do not imply T-lymphocyte involvement in the leukemic process: report of a case with demonstrated "polyclonality" of T lymphocytes J Clin Immunol 3 1983 111 116
25. S.J. Hill, S.H. Peters, M.J. Ayliffe, J. Merceica, and A.S. Bansal Reduced IL-4 and interferon-γ (IFN-γ) expression by CD4 T cells in patients with chronic lymphocytic leukaemia Clin Exp Immunol 117 1999 8 11
26. E. Rossi, E. Matutes, R. Morilla, K. Owusu-Ankomah, A.M. Heffeman, and D. Catovsky Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia Leukemia 10 1996 494 497
27. J.D. Upshaw Jr., and T.R. Callihan Spontaneous remission of B-cell chronic lymphocytic leukemia associated with T lymphocytic hyperplasia in bone marrow South Med J 95 2002 647 649
28. P. Chu, D. Deforce, I.M. Pedersen, Y. Kim, S. Kitada, J.C. Reed, and T.J. Kipps Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukaemia Proc Natl Acad Sci USA 99 2002 3854 3859
29. D. De Totero, M. Montera, O. Rosso, M. Clavio, E. Balleari, R. Foa, and M. Gobbi Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecule expression Hematol J 5 2004 152 160
30. R.R. Furman, Z. Asgary, J.O. Mascarenhas, H.C. Liou, and E.J. Schattner Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukaemia B cells J Immunol 164 2000 2200 2206
31. M. Grdisa Influence of CD40 ligation on survival and apoptosis of B-CLL cells in vitro Leuk Res 27 2003 951 956
32. S. Kitada, J.M. Zapata, M. Andreeff, and J.C. Reed Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia Br J Haematol 106 1999 995 1004
33. M.F. Romano, A. Lamberti, P. Tassone, F. Alfinito, S. Costantini, F. Chiurazzi, T. Defrance, P. Monelli, F. Tuccillo, M.C. Turco, and S. Venuta Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells Blood 92 1998 990 995
34. R.G. Wickremasinghe, K. Ganeshaguru, D.T. Jones, C. Lindsay, V.J. Spanswick, J.A. Hartley, M. Wadhwa, R. Thorpe, A.V. Hoffbrand, H.G. Prentice, and A.B. Mehta Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells Br J Haematol 114 2001 608 615
35. Y. Bomstein, M. Yuklea, J. Radnay, H. Shapiro, F. Afanasyev, S. Yarkoni, and M. Lishner The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia Eur J Haematol 70 2003 290 295
36. P. Ghia, and F. Caligaris-Cappio The nondispensable role of microenvironment in the natural history of low-grade B cell neoplasms Adv Cancer Res 79 2000 157 174
37. L. Lagneaux, A. Delforge, C. De Bruyn, M. Bernier, and D. Bron Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells Leuk Lymphoma 35 1999 445 453
38. P. Panayiotidis, D. Jones, K. Ganeshaguru, L. Foroni, and A.V. Hoffbrand Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro Br J Haematol 92 1996 97 103